Quote: "Parkinsons Disease is more like a movement impairment. Alzheimer's Disease effects the cognition. And the Rett Syndrome is a combination of these factors of cognition and movement. And we found that in the brain, in the central nervous system, there is a constant struggle in these indications - which we call a cellular stress.
And this can be alleviated, or reduced, or compensated by a protein called sigma-1 receptor...and we activate that protein. And we can show that this activation can also be tracked with a blood biomarker. And it shows the correlation of the effect of the drug with the increase of this sigma-1 protein in the blood."
Question from Myles Udland regarding the BP vaccines injecting mRNA vs. Anavex 2-73's MOA.
"So mRNA is the messenger RNA. It's the determination of our protein that gets expressed in the body...which is the functional part of the body - if you so like.
And we were able to show that our drug activates the mRNA. So while [vaccines like] Moderna brings [injects] the mRNA from the outside, we activate the mRNA from the inside - in the body by small molecules. So our drug, A2-73, can be taken orally. Like a mini aspirin..."
Market Data 
Markets 
AI
